Publication | Closed Access
CVS‐3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts
87
Citations
32
References
2004
Year
These results identify CVS-3983 as a potent inhibitor of AI prostate cancer cell invasion in vitro and established xenograft tumor growth in vivo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1